To Prescribe or Not To Prescribe? Antibiotics and Outpatient Infections

Friday, October 21, 2016, 12:00 AM - Friday, October 21, 2022, 12:00 AM, Online Course, Stanford, CA

Internet Enduring Material Sponsored by Stanford University School of Medicine. Presented by the Division of Infectious Diseases in the Department of Medicine at Stanford University School of Medicine

This CME activity provides a practical approach to the management of common outpatient infections through the use of didactic videos, patient role plays and interactive case based video. National guidelines will be reviewed with emphasis on the most appropriate empiric antibiotic choice and duration of therapy. Video role plays will demonstrate communication skills that can be used with patients regarding appropriate antibiotic usage.

Intended Audience
This course is designed for physicians in family practice, primary care, internal medicine, obstetrics and gynecology, emergency medicine, pharmacists, as well as nurse practitioners, physician assistants, and allied health professionals.

  Release Date: October 21, 2016
  Lastest Review Date: October 21, 2019
  Expiration Date: October 21, 2022
  Estimated Time to Complete: 1.75 hours
  CME Credits Offered: 1.75
  Registration Fee: FREE

AMA PRA Category 1 Credits™ (1.75 hours), Non-Physician Participation Credit (1.75 hours)

1. Define the scope and implications of antibiotic misuse in the outpatient setting.
2. Recognize when antimicrobials are indicated in common outpatient infections.
3. Select the most appropriate empiric antimicrobial choice and duration of therapy for common outpatient bacterial infections.
4. Employ effective communication strategies when discussing antibiotic decisions with patients.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 1.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 Accessibility Statement

 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency

The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Bibliography

Antibiotic Resistance Threats in the United States. Centers for Disease Control and Prevention Website. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Published September, 16, 2013. Accessed July 17, 2014.

Linder JA, Doctor JN, Friedberg MW, Reyes Nieva H, et al. Time of day and the decision to prescribe antibiotics. JAMA Intern Med. 2014 Dec;174(12):2029-31.

Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Danziger LH. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. J Antimicrob Chemother. 2013 Mar;68(3):715–8.

For a complete list, please view the References/Bibliography page in the Course.

Disclosures:
The following planners, speakers, and authors have indicated that they have no relationships with industry to disclose relative to the content of this activity:

Stan Deresinski, MD, FIDSA
Clinical Professor of Medicine, Division of Infectious Disease and Geographic Medicine 
Director Stanford Antimicrobial Safety and Sustainability Program 
Stanford University School of Medicine 
Course Director
Speaker

Marisa Holubar, MD, MS
Clinical Assistant Professor of Medicine, Division of Infectious Disease and Geographic Medicine 
Associate Director Stanford Antimicrobial Safety and Sustainability Program 
Stanford University School of Medicine 
Course Director 
Speaker

Elizabeth Robilotti, MD, MPH 
Assistant Attending, Infectious Diseases 
Associate Director, Infection Control 
Memorial Hospital for Cancer and Allied Diseases, 
Memorial Sloan Kettering Cancer Center, New York, NY 
Planner

Lina Meng, PharmD, BCPS 
Antimicrobial Stewardship Pharmacist 
Stanford Hospital and Clinics 
Planner

Emily Mui, PharmD, BCPS 
Antimicrobial Stewardship Pharmacist 
Stanford Hospital and Clinics 
Planner

Katherine E. Fleming-Dutra, MD 
Medical Epidemiologist with the Office of Antibiotic Stewardship  
Division of Healthcare Quality Promotion 
Centers for Disease Control and Prevention (CDC) 
Planner

Lauri Hicks, DO 
Medical Epidemiologist in the Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases 
Centers for Disease Control and Prevention (CDC) 
Planner

The Stanford University School of Medicine has received and has used undesignated program funding from Pfizer, Inc. to facilitate the development of innovative CME activities designed to enhance physician competence and performance and to implement advanced technology.

A portion of this funding supports this activity.